Deborah Schrag, MD, MPH, on Clinical Trial Design: Statistical Options and Challenges

July 15, 2020 By The ASCO Post Staff

Deborah Schrag, MD, MPH, of Dana-Farber Cancer Institute, offers her perspective on near-equivalence, Bayesian noninferiority, and the value of cancer drug optimization.

Related Content